People using proton pump inhibitors (PPIs), such as omeprazole and esomeprazole, are 70% more likely to experience migraines or severe headaches than non-users, according to a study published in ...
The use of bisphosphonates is linked to a reduced risk for fragility fractures in patients with polymyalgia rheumatica on ...
The study found that people taking PPIs had a much higher likelihood of reporting several serious kidney conditions. These ...
SAN DIEGO, March 05, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on ...
A study found no increased risk of neuropsychiatric disorders in children after accounting for shared familial factors. Prenatal exposure to acid-suppressive medications was not associated with ...
GERD affects the lower esophageal sphincter, while LPR affects the upper esophageal sphincter. LPR is a subtype of GERD and can cause symptoms in the throat, like hoarseness and cough. GERD and LPR ...
WASHINGTON — The U.S. Food and Drug Administration has approved a reformulated version of ranitidine, which was sold widely under the brand name Zantac, allowing the acid-reducing drug to return to ...
Proton pump inhibitors are frequently used in neuro-oncology to reduce the risk of gastritis and peptic ulcer disease as a consequence of steroid use. In a meta-analysis, the use of proton pump ...
“In EoE, PPIs are used for anti-inflammatory properties rather than acid suppression,” says Alex Koral, MD, a gastroenterologist and an associate professor of pediatric gastroenterology at Yale School ...
The use of proton pump inhibitors with anti-cancer therapies was associated with worse survival outcomes in patients with breast cancer. Concomitant use of proton pump inhibitors and other everyday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results